Literature DB >> 6187222

Asialoglycoprotein receptor is uninvolved in clearing intact glycoproteins from rat blood.

R Clarenburg.   

Abstract

The hypothesis that the hepatic receptor for asialoglycoproteins would mediate turnover of glycoproteins in blood (after their desialylation by neuraminidase located on cell surfaces) was tested in rats by measuring clearance of intact 125I-labeled glycoproteins in the presence or absence of enough unlabeled asialoglycoproteins to saturate the asialoglycoprotein receptor. Via an indwelling venous catheter, a mixture of 125I-orosomucoid (obtained from rat serum) and a bolus of unlabeled asialofetuin (bovine) was injected, and infusion of an asialofetuin solution sustained. Total radioactivity and trichloroacetic acid-precipitable radioactivity were measured in blood samples taken at frequent intervals from an arterial catheter. Clearance was computer analyzed by using a two-component model. Nondestructiveness of radiolabeling and desialylation methods and interchangeability of rat and bovine (asialo)glycoproteins were demonstrated in control experiments. The infusion trials showed that independent clearance processes exist for intact and asialoglycoproteins. Apparently, the asialoglycoprotein receptor has no function in the turnover of intact plasma glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187222     DOI: 10.1152/ajpgi.1983.244.3.G247

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Chylomicron remnant and asialoglycoprotein metabolism are independent.

Authors:  A D Cooper; D Coleman
Journal:  Lipids       Date:  1985-10       Impact factor: 1.880

2.  In vivo quantification of removal of asialo-orosomucoid from the circulation in anaesthetized streptozotocin-diabetic rats.

Authors:  M Appel; P Potrat; J Feger; C Mas-Chamberlin; G Durand
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

3.  Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation.

Authors:  C Kronman; B Velan; D Marcus; A Ordentlich; S Reuveny; A Shafferman
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

4.  Erythropoiesis stimulating agents: approaches to modulate activity.

Authors:  Angus M Sinclair
Journal:  Biologics       Date:  2013-07-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.